Jankowska et al., 2014 - Google Patents
Comparison of clinical profile and management of outpatients with heart failure with reduced left ventricular ejection fraction treated by general practitioners and …Jankowska et al., 2014
View PDF- Document ID
- 10816318160526944984
- Author
- Jankowska E
- Kalicinska E
- Drozd M
- Kurian B
- Banasiak W
- Ponikowski P
- Publication year
- Publication venue
- International journal of cardiology
External Links
Snippet
Objective We sought to determine and compare clinical profile and management of outpatients with heart failure with reduced ejection fraction (HFREF) treated by cardiologists and general practitioners (GPs) in Poland. Methods All the 790 randomly selected …
- 206010007554 Cardiac failure 0 title abstract description 91
Classifications
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/32—Medical data management, e.g. systems or protocols for archival or communication of medical images, computerised patient records or computerised general medical references
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/34—Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/04—Detecting, measuring or recording bioelectric signals of the body of parts thereof
- A61B5/0402—Electrocardiography, i.e. ECG
- A61B5/0452—Detecting specific parameters of the electrocardiograph cycle
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
- G06Q50/10—Services
- G06Q50/22—Health care, e.g. hospitals; Social work
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Arbelo et al. | Contemporary management of patients undergoing atrial fibrillation ablation: in-hospital and 1-year follow-up findings from the ESC-EHRA atrial fibrillation ablation long-term registry | |
Poole et al. | Long-term outcomes of implantable cardioverter-defibrillator therapy in the SCD-HeFT | |
Tardif et al. | Effects of selective heart rate reduction with ivabradine on left ventricular remodelling and function: results from the SHIFT echocardiography substudy | |
Newby et al. | ACCF 2012 expert consensus document on practical clinical considerations in the interpretation of troponin elevations: a report of the American College of Cardiology Foundation task force on Clinical Expert Consensus Documents | |
Maron et al. | Hypertrophic cardiomyopathy in adulthood associated with low cardiovascular mortality with contemporary management strategies | |
Wyse et al. | Lone atrial fibrillation: does it exist? | |
Huikuri et al. | Prediction of fatal or near-fatal cardiac arrhythmia events in patients with depressed left ventricular function after an acute myocardial infarction | |
Jankowska et al. | Comparison of clinical profile and management of outpatients with heart failure with reduced left ventricular ejection fraction treated by general practitioners and cardiologists in contemporary Poland: the results from the DATA-HELP registry | |
Barbieri et al. | Prognostic and therapeutic implications of pulmonary hypertension complicating degenerative mitral regurgitation due to flail leaflet: a multicenter long-term international study | |
Fonarow et al. | Carvedilol use at discharge in patients hospitalized for heart failure is associated with improved survival: an analysis from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF) | |
Poelzl et al. | Dose matters! Optimisation of guideline adherence is associated with lower mortality in stable patients with chronic heart failure | |
Kandala et al. | QRS morphology, left ventricular lead location, and clinical outcome in patients receiving cardiac resynchronization therapy | |
Geske et al. | Surgical myectomy improves pulmonary hypertension in obstructive hypertrophic cardiomyopathy | |
Collet et al. | Systematic detection of polyvascular disease combined with aggressive secondary prevention in patients presenting with severe coronary artery disease: The randomized AMERICA Study | |
Kim et al. | Outcomes in patients with cardiac amyloidosis and implantable cardioverter-defibrillator | |
Wenger et al. | Coronary heart disease in women: update 2008 | |
Chang et al. | Recovery of left ventricular dysfunction after sacubitril/valsartan: predictors and management | |
Liang et al. | Long-term outcomes in survivors of early ventricular arrhythmias after acute ST-elevation and non–ST-elevation myocardial infarction treated with percutaneous coronary intervention | |
Elsheikh et al. | Atrial fibrillation and stroke: State-of-the-art and future directions | |
Liang et al. | Outcomes in patients with sustained ventricular tachyarrhythmias occurring within 48 h of acute myocardial infarction: when is ICD appropriate? | |
Rosman et al. | The association between admission systolic blood pressure of heart failure patients with preserved systolic function and mortality outcomes | |
Skrebelyte-Strøm et al. | Prediction of occult atrial fibrillation in patients after cryptogenic stroke and transient ischaemic attack: PROACTIA | |
Trines et al. | Influence of risk factors in the ESC‐EHRA EORP atrial fibrillation ablation long‐term registry | |
Ciabatti et al. | Prevalence, causes and predictors of cardiovascular hospitalization in patients with hypertrophic cardiomyopathy | |
Wita et al. | Managed Care after Acute Myocardial Infarction (MC-AMI)–a Poland’s nationwide program of comprehensive post-MI care-improves prognosis in 12-month follow-up. Preliminary experience from a single high-volume center |